Our study here shows that the high expression of FKBP1A in LIHC patients may regulate the TGF-β signaling pathways to speed up the multiplication including cell proliferation, apoptosis or autophagy, inhibition of angiogenesis and inflammatory signals of the cancer cells according to KEGG pathway analysis from the STRING database. The gene discussed is FKBP1A; the disease is cancer.